December 28, 2017 / 2:06 PM / a year ago

BRIEF-Odonate Therapeutics Announces Initiation Of CONTESSA, A Phase 3 Study Of Tesetaxel In Patients With Locally Advanced Or Metastatic Breast Cancer

Dec 28 (Reuters) - Odonate Therapeutics Inc:

* ODONATE THERAPEUTICS ANNOUNCES INITIATION OF CONTESSA, A PHASE 3 STUDY OF TESETAXEL IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BREAST CANCER Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below